Cite
Additional file 2 of CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study
MLA
Otsuka, Tomoyuki, et al. Additional File 2 of CpG ODN (K3)—toll-like Receptor 9 Agonist—induces Th1-Type Immune Response and Enhances Cytotoxic Activity in Advanced Lung Cancer Patients: A Phase I Study. Jan. 2022. EBSCOhost, https://doi.org/10.6084/m9.figshare.20267679.v1.
APA
Otsuka, T., Nishida, S., Shibahara, T., Temizoz, B., Hamaguchi, M., Shiroyama, T., Kimura, K., Miyake, K., Hirata, H., Mizuno, Y., Yagita, M., Manabe, Y., Kuroda, E., Takeda, Y., Kida, H., Ishii, K. J., & Kumanogoh, A. (2022). Additional file 2 of CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study. https://doi.org/10.6084/m9.figshare.20267679.v1
Chicago
Otsuka, Tomoyuki, Sumiyuki Nishida, Takayuki Shibahara, Burcu Temizoz, Masanari Hamaguchi, Takayuki Shiroyama, Keiko Kimura, et al. 2022. “Additional File 2 of CpG ODN (K3)—toll-like Receptor 9 Agonist—induces Th1-Type Immune Response and Enhances Cytotoxic Activity in Advanced Lung Cancer Patients: A Phase I Study,” January. doi:10.6084/m9.figshare.20267679.v1.